Lowering the Piperacillin-Tazobactam break point for susceptibility to pseudomonas aeruginosa: does this affect outcomes in bacteremic patients?
Citation: Unknown 2014 MayInstitution: MedStar Washington Hospital CenterDepartment: Medicine/Infectious Diseases | Medicine/Pulmonary/Critical CareForm of publication: ConferenceYear: 2014Conference information: Paper presented at: American Thoracic Society International Conference, San Diego, CA, Fiscal year: FY201426Local accession number: 2014.1_1Date added to catalog: 2016-06-02| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Conference | MedStar Authors Catalog | Conference | Available |